z-logo
Premium
Sedoheptulokinase deficiency due to a 57‐kb deletion in cystinosis patients causes urinary accumulation of sedoheptulose: elucidation of the CARKL gene
Author(s) -
Wamelink Mirjam M.C.,
Struys Eduard A.,
Jansen Erwin E.W.,
Levtchenko Ele.,
Zijlstra Fokje S.M.,
Engelke Udo,
Blom Henk J.,
Jakobs Cornelis,
Wevers Ron A.
Publication year - 2008
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.20685
Subject(s) - cystinosis , biology , medicine , cystine , mutation , biochemistry , endocrinology , gene , enzyme , cysteine
The most common mutation in the nephropathic cystinosis ( CTNS ) gene is a homozygous 57‐kb deletion that also includes an adjacent gene carbohydrate kinase‐like ( CARKL ). The latter gene encodes a protein that is predicted to function as a carbohydrate kinase. Cystinosis patients with the common 57‐kb deletion had strongly elevated urinary concentrations of sedoheptulose (28–451 mmol/mol creatinine; controls and other cystinosis patients <9) and erythritol (234–1110 mmol/mol creatinine; controls and other cystinosis patients <148). Enzyme studies performed on fibroblast homogenates derived from patients carrying the 57‐kb deletion revealed 80% reduction in their sedoheptulose phosphorylating activity compared to cystinosis patients with other mutations and controls. This indicates that the CARKL‐encoded protein, sedoheptulokinase (SHK), is responsible for the reaction: sedoheptulose + ATP → sedoheptulose‐7‐phosphate + ADP and that deletion of CARKL causes urinary accumulation of sedoheptulose and erythritol. Hum Mutat 29(4), 532–536, 2008. © 2008 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom